Abbott lands expanded approval for Absolute Pro stent system

February 27, 2012 by MassDevice staff

Abbott lands a PMA win for its Absolute Pro stent, expanding its indication to treat patients with narrowing of the iliac arteries.

Absolute Pro stent

Abbott (NYSE:ABT) won expanded pre-market approval from the FDA for its Absolute Pro self-expanding stent system, according to an agency release.

The next-generation device, delivered via catheter, is now additionally indicated for use in narrowed iliac arteries.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.